Publications by authors named "Gaoqin Yi"

Article Synopsis
  • The study focused on a newly isolated strain of L.reuteri LY2-2 to understand its effects on colitis in mice and the mechanisms involved.
  • Mice with DSS-induced colitis showed significantly reduced disease severity after being treated with L.reuteri LY2-2, as it helped lower inflammation and improved gut health by balancing gut bacteria.
  • The findings suggest that L.reuteri LY2-2 may be a more effective probiotic treatment for colitis than traditional drugs like 5-ASA, providing insights for developing functional probiotics for better human health.
View Article and Find Full Text PDF

No approved effective therapy for non-alcoholic steatohepatitis (NASH) is currently available. Trichinella spiralis (T. spiralis) infection and their products have positive impact on several metabolic diseases.

View Article and Find Full Text PDF

Nonalcoholic fatty liver disease (NAFLD) is a liver disease characterized by hepatic steatosis, inflammation, and fibrosis, as well as gut dysbiosis. No approved effective therapeutic medicine is available to date for NAFLD. Helminth therapy is believed to be a novel direction and therapeutic strategy for NAFLD.

View Article and Find Full Text PDF